Basic information Safety Supplier Related

Valganciclovir

Basic information Safety Supplier Related

Valganciclovir Basic information

Product Name:
Valganciclovir
Synonyms:
  • valganciclovir
  • Valganciclovir & Valganciclovir Hydrochloride
  • Valganciclovir-d8
  • (2S)-2-((2-AMino-6-oxo-1H-purin-9(6H)-yl)Methoxy)-3-hydroxypropyl 2-aMino-3-Methylbutanoate
  • 5-amino-3-[1-(hydroxymethyl)-2-(l-valyloxy)ethoxymethyl]-6,7- dihydro-3h-imidazo[4,5-d]pyrimidin-7-one
  • Valgancyclovir
  • Valganciclovir-d5 HCl (Mixture of diastetroMers)
  • Valganciclovir-d8 (Mixture of Diastereomers)
CAS:
175865-60-8
MF:
C14H22N6O5
MW:
354.36
EINECS:
1312995-182-4
Product Categories:
  • API
Mol File:
175865-60-8.mol
More
Less

Valganciclovir Chemical Properties

Density 
1.59±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
pka
9.32±0.20(Predicted)
BCS Class
3
CAS DataBase Reference
175865-60-8(CAS DataBase Reference)
More
Less

Safety Information

Hazardous Substances Data
175865-60-8(Hazardous Substances Data)
More
Less

Valganciclovir Usage And Synthesis

Uses

Antiviral.

Uses

Valganciclovir-d8, is the labeled analogue of Valganciclovir (V092000), a pro-drug of Ganciclovir, used in treatment of retro-virus.

Definition

ChEBI: The L-valinyl ester of ganciclovir, into which it is rapidly converted by intestinal and hepatic esterases. It is a synthetic analogue of 2'-deoxyguanosine.

Indications

Valganciclovir (Valcyte) is the L-valyl ester prodrug of ganciclovir.

brand name

Valcyte (Roche).

Clinical Use

Oral valganciclovir is comparable to intravenous ganciclovir for the treatment and suppression of CMV retinitis in AIDS patients.

Drug interactions

Potentially hazardous interactions with other drugs
Antibacterials: increased risk of convulsions with imipenem-cilastatin.
Antivirals: possibly increased didanosine concentration; profound myelosuppression with zidovudine - avoid if possible.
Mycophenolate: possibly increased concentrations of both mycophenolic acid and ganciclovir.
Increased risk of myelosuppression with other myelosuppressive drugs.

Metabolism

Valganciclovir is well absorbed from the gastrointestinal tract and rapidly and extensively metabolised in the intestinal wall and liver to ganciclovir. Valganciclovir is eliminated in the urine as unchanged ganciclovir, mainly by glomerular filtration and also active tubular secretion.

ValganciclovirSupplier

Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768850
Email
1791901229@qq.com
Daicel Chiral Technologies (China)CO.,LTD
Tel
021-50460086-9 15921403865
Email
han_yajun@dctc.daicel.com
China Langchem Inc.
Tel
0086-21-58956006
Shanghai Fuhe Chemistry Technology Co., Ltd.
Tel
0086-21-67651709
Email
cfx759@hotmail.com